| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &Chief Medical Officer | Chief Medical Officer
1 company
Duliege Anne-Marie is an EVP &Chief Medical Officer at RIGEL PHARMACEUTICALS INC. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $4.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 17, 2018 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Medical Officer | Sale+OE | 153,000 | $3.50 | $535,500.00 | -100% | |
| Sep 4, 2018 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Medical Officer | Sale+OE | 16,500 | $3.51 | $57,860.55 | -100% | |
| Jul 2, 2018 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Medical Officer | Sell | 5,000 | $2.79 | $13,932.00 | -100% | |
| Apr 20, 2018 | RIGL Rigel Pharmaceuticals Inc | EVP &Chief Medical Officer | Sell | 5,000 | $4.11 | $20,550.00 | -100% | |
| Jul 5, 2017 | RIGL Rigel Pharmaceuticals Inc | Chief Medical Officer | Sell | 5,000 | $2.69 | $13,427.00 | -100% | |
| Jan 3, 2017 | RIGL Rigel Pharmaceuticals Inc | Chief Medical Officer | Sell | 5,000 | $2.41 | $12,027.50 | -100% |